UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035708
Receipt number R000040661
Scientific Title examination of effectiveness and safety of oral immunization for food allergy patients
Date of disclosure of the study information 2019/02/08
Last modified on 2023/02/02 11:27:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

examination of effectiveness and safety of oral immunization for food allergy patients

Acronym

oral immunization for food allergy

Scientific Title

examination of effectiveness and safety of oral immunization for food allergy patients

Scientific Title:Acronym

oral immunization for food allergy

Region

Japan


Condition

Condition

food allergy

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

determine safety and effectiveness of oral immunotherapy for food allergy patient

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

Intake of any dose of allergen without symptom

Key secondary outcomes

Intake of small dose of allergen without symptom


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

taking of allergen food

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

240 months-old >=

Gender

Male and Female

Key inclusion criteria

complete elimination diet with history of anaphylaxis

Key exclusion criteria

patient who have been produced anaphylaxis by a trace of allergen

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Takeshima

Organization

Hyogo College Of Medicine

Division name

pediatric department

Zip code

663-8501

Address

Mukogawa 1-1,Nishinomiya city,Hyogo pref. Japan

TEL

0798-45-6352

Email

ped-ped@hyo-med.ac.jp


Public contact

Name of contact person

1st name Yasuhiko
Middle name
Last name Tanaka

Organization

Hyogo College Of Medicine

Division name

pediatric department

Zip code

663-8501

Address

Mukogawa 1-1,Nishinomiya city,Hyogo pref. Japan

TEL

0798-45-6352

Homepage URL


Email

tana-ped@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College Of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College Of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo College Of Medicine

Address

Mukogawa 1-1,Nishinomiya city,Hyogo pref. Japan

Tel

0798-45-6352

Email

tana-ped@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 02 Month 01 Day

Date of IRB

2016 Year 01 Month 16 Day

Anticipated trial start date

2019 Year 02 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 29 Day

Last modified on

2023 Year 02 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040661


Research Plan
Registered date File name
2019/01/29 経口免疫療法・実施計画書.doc

Research case data specifications
Registered date File name

Research case data
Registered date File name